ArticleMultiple sclerosis and related disorders2022

Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod.

Rocco Capuano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.